Peptide Clinical Trials Brief — June 02, 2026 is part of the Novusyn Research editorial desk. Weekly ClinicalTrials.gov digest: CagriSema Phase 3, Roche enicepatide pivotal trials, tirzepatide expansions, and MariTide updates. This prerendered HTML exists so crawlers see route-specific content before the client app hydrates.
For adjacent coverage, see the news desk, clinical trials tracker, regulation tracker, guides library, and the compound directory. Novusyn Research publishes neutral, research-only reference material and does not sell compounds or provide medical advice.